First Trust Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-84,967
| Closed | -$926K | – | 2616 |
|
|
2022
Q2 | $926K | Sell |
84,967
-896
| -1% | -$9.77K | ﹤0.01% | 2015 |
|
|
2022
Q1 | $971K | Sell |
85,863
-4,957
| -5% | -$56.1K | ﹤0.01% | 2051 |
|
|
2021
Q4 | $1.43M | Buy |
90,820
+10,525
| +13% | +$165K | ﹤0.01% | 1924 |
|
|
2021
Q3 | $1.38M | Buy |
+80,295
| New | +$1.38M | ﹤0.01% | 1919 |
|
|
2019
Q2 | – | Sell |
-128,598
| Closed | -$2.37M | – | 2510 |
|
|
2019
Q1 | $2.37M | Buy |
128,598
+22,724
| +21% | +$418K | ﹤0.01% | 1453 |
|
|
2018
Q4 | $2.77M | Buy |
+105,874
| New | +$2.77M | 0.01% | 1290 |
|
|
2017
Q4 | – | Sell |
-69,942
| Closed | -$1.25M | – | 2466 |
|
|
2017
Q3 | $1.25M | Buy |
69,942
+157
| +0.2% | +$2.81K | ﹤0.01% | 1749 |
|
|
2017
Q2 | $1.14M | Buy |
+69,785
| New | +$1.14M | ﹤0.01% | 1790 |
|